posted on 2018-05-15, 20:13authored byScott
J. Barraza, Scott E. Denmark
Silicon-containing
compounds have been largely ignored in drug
design and development, despite their potential to improve not only
the potency but also the physicochemical and ADMET (absorption, distribution, metabolism, excretion, toxicity) properties of drug-like
candidates because of the unique characteristics of silicon. This
deficiency is in large part attributable to a lack of general methods
for synthesizing diverse organosilicon structures. Accordingly, a
new building block strategy has been developed that diverges from
traditional approaches to incorporation of silicon into drug candidates.
Flexible, multi-gram-scale syntheses of silicon-containing tetrahydroquinoline
and tetrahydroisoquinoline building blocks are described, along with
methods by which diversely functionalized silicon-containing nitrogen
heterocycles can be rapidly built using common reactions optimized
to accommodate the properties of silicon. Furthermore, to better clarify
the liabilities and advantages of silicon incorporation, select compounds
and their carbon analogues were challenged in ADMET-focused biological
studies.